Thursday, May 24, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Drug Discovery
Pfizer global R&D: today and tomorrow
Dr John L LaMattina, President of Pfizer Global Research & Development, says we should be looking beyond its disclosed pipeline…
No Comments
Optimizing the discovery engine
The natural evolution of clusters to accelerate the pace of drug discovery
No Comments
Evaluating Challenges to Clinical Trial Execution
Evaluating Challenges to Clinical Trial Execution
Garrett D. Smith, Accelovance, Marketing & Patient Recruitment
No Comments
Head to head: The hard cell
Two experts go head to head on the challenges still to be overcome in understanding exactly how genes interplay to develop future targeted treatments.
No Comments
Head to head: The hard cell
Two experts go head to head on the challenges still to be overcome in understanding exactly how genes interplay to develop future targeted treatments.
No Comments
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.